| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/25/1997 | US5605822 Culturing human stem cells in liquid culture medium in the presence of transformed stromal cells |
| 02/25/1997 | US5605821 Expression control sequences of the P-selectin gene |
| 02/25/1997 | US5605818 From culture medium containing corynebacterium or brevibacterium |
| 02/25/1997 | US5605817 DNA encoding chemokine expressed in fetal spleen |
| 02/25/1997 | US5605816 Transforming eukaryotic cell with vector; expression; cultures |
| 02/25/1997 | US5605814 DNA encoding human prostaglandin receptor EP2 |
| 02/25/1997 | US5605808 Oncoprotein protein kinase |
| 02/25/1997 | US5605804 Monitoring course of disease in patient by performing series of immunoassays over time to determine changes in level of nonspecific crosssreacting antigen 50/90 in blood samples |
| 02/25/1997 | US5605803 Human sperm diagnostic |
| 02/25/1997 | US5605801 Performing restriction fragment length polymorphism analysis, differentiating between wild type and mutant alleles by detecting different number of restriction sites |
| 02/25/1997 | US5605798 Detecting target nucleic acid sequences |
| 02/25/1997 | US5605793 Adding to cleaved random double stranded fragments one or more single stranded or double stranded oligonucleotides, denaturing into single stranded fragments, incubating |
| 02/25/1997 | US5605692 Polypeptide |
| 02/25/1997 | US5605689 Treatment of HIV-associated immune thrombocytopenic purpura |
| 02/25/1997 | US5605688 Recombinant dog and horse type I interferons |
| 02/25/1997 | US5605662 Used to carry out and control multistep, muliplex reactions such as, nucleic acid hybridization, antibody/antigen reactions, biopolymer synthesis |
| 02/25/1997 | US5605011 Nucleic acid fragment encoding herbicide resistant plant acetolactate synthase |
| 02/25/1997 | CA2078805C Cytokine preparation |
| 02/25/1997 | CA1338931C Multiplying bovine embryos |
| 02/23/1997 | CA2183606A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/20/1997 | WO1997006435A1 Improvements in or relating to methods of screening substances |
| 02/20/1997 | WO1997006420A1 Apparatus for the parallel alignment of macromolecules, and use thereof |
| 02/20/1997 | WO1997006277A1 Methods for drug screening |
| 02/20/1997 | WO1997006276A1 Co-dominant genetic diagnosis test |
| 02/20/1997 | WO1997006272A2 High efficiency helper system for aav vector production |
| 02/20/1997 | WO1997006271A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 02/20/1997 | WO1997006270A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 02/20/1997 | WO1997006269A1 Inducible herbicide resistance |
| 02/20/1997 | WO1997006268A2 Dna constructs |
| 02/20/1997 | WO1997006267A2 Genetic transformation using a parp inhibitor |
| 02/20/1997 | WO1997006266A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 02/20/1997 | WO1997006265A2 Recombinant clone selection system |
| 02/20/1997 | WO1997006264A1 Bacterial peptide library |
| 02/20/1997 | WO1997006262A1 Non-receptor type human protein tyrosine phosphatase |
| 02/20/1997 | WO1997006261A2 THE USE OF HOMOLOGOUS amdS GENES AS SELECTABLE MARKERS |
| 02/20/1997 | WO1997006260A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/20/1997 | WO1997006259A2 Resistance against wilt inducing fungi |
| 02/20/1997 | WO1997006258A2 cDNA SEQUENCE, AMINO-ACID SEQUENCE, DERIVED FROM THE cDNA SEQUENCE, OF THE PRECURSOR PROTEIN OF HUMAN GCAP-II/UROGUANYLINE, AND AMINO-ACID SEQUENCE OF THE FRAGMENT CIRCULATING IN HUMAN BLOOD |
| 02/20/1997 | WO1997006257A1 Cellular co-factor for hiv rev and htlv rex |
| 02/20/1997 | WO1997006256A2 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | WO1997006255A2 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods |
| 02/20/1997 | WO1997006254A1 Human mp52 arg protein |
| 02/20/1997 | WO1997006253A1 Method of modulating gene expression with reduced immunostimulatory response |
| 02/20/1997 | WO1997006252A1 Synthetic oligonucleotides with enhanced ribonuclease activity |
| 02/20/1997 | WO1997006251A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-α RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-α AND ITS ANALOGUES |
| 02/20/1997 | WO1997006250A1 Nuclear-encoded transcription system in plastids of higher plants |
| 02/20/1997 | WO1997006247A2 Deubiquitinating enzymes that regulate cell growth |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997006241A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | WO1997006183A1 Cationic oligonucleotides, and related methods of synthesis and use |
| 02/20/1997 | WO1997006181A1 Production of xylanase and cellulase in b. subtilis |
| 02/20/1997 | WO1997006180A1 Detecting genetic predisposition to periodontal disease |
| 02/20/1997 | WO1997006176A2 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | WO1997005771A2 Lysosomal proteins produced in the milk of transgenic animals |
| 02/20/1997 | WO1997002730A3 Enamel matrix related polypeptide |
| 02/20/1997 | WO1996040260A3 Immunotoxins specific for cd80 and cd86 expressing cells |
| 02/20/1997 | WO1996039512A3 A cell line for the rapid expression of functional calcium channels |
| 02/20/1997 | WO1996036711A3 Islet-specific homeoprotein and transcriptional regulator of insulin gene expression |
| 02/20/1997 | DE19544374C1 New plasmid contg. luciferase gene controlled by bacterial SOS promoter |
| 02/20/1997 | DE19530412A1 Selbst deletierende retrovirale Vektoren für die Gentherapie Even deletierende retroviral vectors for gene therapy |
| 02/20/1997 | DE19530132A1 Verfahren zur Reinigung, Stabilisierung oder Isolierung von Nukleinsäuren aus biologischen Materialien Method for purifying, stabilizing or isolating nucleic acids from biological materials |
| 02/20/1997 | DE19530107A1 Verfahren zur gezielten Veränderung von Zell-DNA Methods for the targeted modification of cellular DNA |
| 02/20/1997 | CA2512366A1 Mammalian iap gene family, primers, probes and detection methods |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | CA2228999A1 Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis |
| 02/20/1997 | CA2228694A1 Co-dominant genetic diagnosis test |
| 02/20/1997 | CA2228512A1 Peptide and o-glycan inhibitors of selectin mediated inflammation |
| 02/20/1997 | CA2227584A1 Transgenic swine and swine cells having human hla genes |
| 02/20/1997 | CA2227524A1 Resistance against wilt inducing fungi |
| 02/20/1997 | CA2227445A1 Dna constructs |
| 02/20/1997 | CA2227204A1 Human mp52 arg protein |
| 02/20/1997 | CA2225680A1 Improvements in or relating to methods of screening substances |
| 02/20/1997 | CA2224732A1 Inducible herbicide resistance |
| 02/20/1997 | CA2201963A1 Cationic oligonucleotides, and related methods of synthesis and use |
| 02/20/1997 | CA2201481A1 Vectors and process for producing high purity 6,12-dideoxyerythromycin a by fermentation |
| 02/20/1997 | CA2201282A1 Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 02/19/1997 | EP0758682A2 Hepatocyte growth factor activator inhibitor |
| 02/19/1997 | EP0758681A2 Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 02/19/1997 | EP0758679A1 Process for producing 2-keto-l-gulonic acid |
| 02/19/1997 | EP0758405A1 Method of nucleic acid transfer |
| 02/19/1997 | EP0758404A1 Detection of fungal pathogens using the polymerase chain reaction |
| 02/19/1997 | EP0758402A1 Nucleic acid mutation assays |
| 02/19/1997 | EP0758400A1 Method and apparatus for counting cells and microorganisms, particularly in food and biological fluids |
| 02/19/1997 | EP0758397A1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 02/19/1997 | EP0758396A1 Feline immunodeficiency virus vaccine |
| 02/19/1997 | EP0758395A1 Improvements in or relating to disease-resistance of plants |
| 02/19/1997 | EP0758394A1 Bifunctional protein, preparation and use |
| 02/19/1997 | EP0758393A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
| 02/19/1997 | EP0758392A1 Functional expression of mammalian adenylyl cyclase in yeast |
| 02/19/1997 | EP0758391A1 METALLOPROTEASES FROM $i(FUSARIUM) AND $i(ASPERGILLUS) HAVING THERMOLYSIN-LIKE ACTIVITY |
| 02/19/1997 | EP0758390A1 Angiostatin and method of use for inhibition of angiogenesis |
| 02/19/1997 | EP0758389A1 Subtilisin 309 variants having decreased adsorption and increased hydrolysis |
| 02/19/1997 | EP0758388A1 Subtilisin bpn' variants having decreased adsorption and increased hydrolysis |
| 02/19/1997 | EP0758387A1 Thymidine kinase mutants |
| 02/19/1997 | EP0758386A1 Novel enzymatic rna molecules |
| 02/19/1997 | EP0758385A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens |
| 02/19/1997 | EP0758384A1 Leishmania major protein, nucleic acid coding therefor, and uses thereof |
| 02/19/1997 | EP0758383A1 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 02/19/1997 | EP0758382A1 Enhancing the sensitivity of tumor cells to therapies |
| 02/19/1997 | EP0758381A1 Biologically active eph family ligands |